Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2016 1
2017 1
2019 1
2020 5
2021 5
2022 12
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Atypical glandular cells and predictive features of malignancy in Pap smears: A retrospective monocentric study.
Cianfrini F, d'Amati A, Arciuolo D, Travaglino A, D'Alessandris N, Scaglione G, Valente M, Urtueta BP, Addante F, Narducci N, Angelico G, Piermattei A, Mulè A, Santoro A, Rossi ED, Zannoni GF. Cianfrini F, et al. Among authors: piermattei a. Cytopathology. 2024 Apr 30. doi: 10.1111/cyt.13383. Online ahead of print. Cytopathology. 2024. PMID: 38686982
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
Addante F, d'Amati A, Santoro A, Angelico G, Inzani F, Arciuolo D, Travaglino A, Raffone A, D'Alessandris N, Scaglione G, Valente M, Tinnirello G, Sfregola S, Padial Urtueta B, Piermattei A, Cianfrini F, Mulè A, Bragantini E, Zannoni GF. Addante F, et al. Among authors: piermattei a. Int J Mol Sci. 2024 Jan 15;25(2):1056. doi: 10.3390/ijms25021056. Int J Mol Sci. 2024. PMID: 38256131 Free PMC article. Review.
Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
Scaglione G, Arciuolo D, Travaglino A, Santoro A, Angelico G, Spadola S, Inzani F, D'Alessandris N, Raffone A, Fulgione C, Padial Urtueta B, Sfregola S, Valente M, Addante F, d'Amati A, Cianfrini F, Piermattei A, Pedone Anchora L, Scambia G, Ferrandina G, Zannoni GF. Scaglione G, et al. Among authors: piermattei a. Diagnostics (Basel). 2023 Oct 17;13(20):3228. doi: 10.3390/diagnostics13203228. Diagnostics (Basel). 2023. PMID: 37892049 Free PMC article.
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
Sokolenko A, Preobrazhenskaya E, Marchetti C, Piermattei A, Zagrebin F, Kuligina E, Gorodnova T, Pavone M, Ivantsov A, Bizin I, Scambia G, Berlev I, Fagotti A, Imyanitov E. Sokolenko A, et al. Among authors: piermattei a. Pathobiology. 2024;91(2):108-113. doi: 10.1159/000533591. Epub 2023 Aug 14. Pathobiology. 2024. PMID: 37579727
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, Sillano F, Buttarelli M, Piermattei A, Loverro M, Camarda F, Greco V, De Bonis M, Minucci A, Gallo D, Urbani A, Vizzielli G, Scambia G, Sette C. Cesari E, et al. Among authors: piermattei a. J Exp Clin Cancer Res. 2023 May 18;42(1):126. doi: 10.1186/s13046-023-02682-5. J Exp Clin Cancer Res. 2023. PMID: 37202753 Free PMC article.
Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors.
Santoro A, Inzani F, Angelico G, Arciuolo D, Bragantini E, Travaglino A, Valente M, D'Alessandris N, Scaglione G, Sfregola S, Piermattei A, Cianfrini F, Roberti P, Zannoni GF. Santoro A, et al. Among authors: piermattei a. Cancers (Basel). 2023 Feb 10;15(4):1137. doi: 10.3390/cancers15041137. Cancers (Basel). 2023. PMID: 36831480 Free PMC article. Review.
Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study.
Bizzarri N, Arciuolo D, Certelli C, Pedone Anchora L, Gallotta V, Teodorico E, Carbone MV, Piermattei A, Fanfani F, Fagotti A, Ferrandina G, Zannoni GF, Scambia G, Querleu D. Bizzarri N, et al. Among authors: piermattei a. Cancers (Basel). 2023 Feb 9;15(4):1099. doi: 10.3390/cancers15041099. Cancers (Basel). 2023. PMID: 36831442 Free PMC article.
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
Turco LC, Pedone Anchora L, Fedele C, Inzani F, Piermattei A, Martini M, Volpe M, Marchetti S, Santangelo R, Bizzarri N, Cosentino F, Vargiu V, De Ninno M, Macchia G, Valentini V, Zannoni G, Scambia G, Ferrandina G. Turco LC, et al. Among authors: piermattei a. Int J Gynecol Cancer. 2023 Apr 3;33(4):489-497. doi: 10.1136/ijgc-2022-003940. Int J Gynecol Cancer. 2023. PMID: 36720505
Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis.
Travaglino A, Arciuolo D, Santoro A, Raffone A, Pedone Anchora L, Piermattei A, Martinelli M, Mollo A, Onori ME, Minucci A, Inzani F, Fanfani F, Insabato L, Zannoni GF. Travaglino A, et al. Among authors: piermattei a. Virchows Arch. 2023 Apr;482(4):671-678. doi: 10.1007/s00428-022-03472-8. Epub 2022 Dec 23. Virchows Arch. 2023. PMID: 36550216
36 results